Global Non-24-hour Sleep-wake Disorder Treatment Supply, Demand and Key Producers, 2023-2029
The global Non-24-hour Sleep-wake Disorder Treatment market size is expected to reach $ 734.7 million by 2029, rising at a market growth of 5.8% CAGR during the forecast period (2023-2029).
Non-24-hour sleep-wake disorder (N24) is a circadian rhythm sleep disorder in which an individual's biological clock fails to synchronize to a 24-hour day. Instead of sleeping at roughly the same time every day, someone with N24 will typically find their sleep time gradually delaying by minutes to hours every day.
This report studies the global Non-24-hour Sleep-wake Disorder Treatment demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Non-24-hour Sleep-wake Disorder Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-24-hour Sleep-wake Disorder Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Non-24-hour Sleep-wake Disorder Treatment total market, 2018-2029, (USD Million)
Global Non-24-hour Sleep-wake Disorder Treatment total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Non-24-hour Sleep-wake Disorder Treatment total market, key domestic companies and share, (USD Million)
Global Non-24-hour Sleep-wake Disorder Treatment revenue by player and market share 2018-2023, (USD Million)
Global Non-24-hour Sleep-wake Disorder Treatment total market by Type, CAGR, 2018-2029, (USD Million)
Global Non-24-hour Sleep-wake Disorder Treatment total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Non-24-hour Sleep-wake Disorder Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Mylan, Nature’s Bounty, Otsuka Pharma (Pharmavite), Boiron, Miers Laboratories, Genexa, Homeocan and Clinigen Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Non-24-hour Sleep-wake Disorder Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Non-24-hour Sleep-wake Disorder Treatment Market, By Region:
1. How big is the global Non-24-hour Sleep-wake Disorder Treatment market?
2. What is the demand of the global Non-24-hour Sleep-wake Disorder Treatment market?
3. What is the year over year growth of the global Non-24-hour Sleep-wake Disorder Treatment market?
4. What is the total value of the global Non-24-hour Sleep-wake Disorder Treatment market?
5. Who are the major players in the global Non-24-hour Sleep-wake Disorder Treatment market?
6. What are the growth factors driving the market demand?
Non-24-hour sleep-wake disorder (N24) is a circadian rhythm sleep disorder in which an individual's biological clock fails to synchronize to a 24-hour day. Instead of sleeping at roughly the same time every day, someone with N24 will typically find their sleep time gradually delaying by minutes to hours every day.
This report studies the global Non-24-hour Sleep-wake Disorder Treatment demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Non-24-hour Sleep-wake Disorder Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-24-hour Sleep-wake Disorder Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Non-24-hour Sleep-wake Disorder Treatment total market, 2018-2029, (USD Million)
Global Non-24-hour Sleep-wake Disorder Treatment total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Non-24-hour Sleep-wake Disorder Treatment total market, key domestic companies and share, (USD Million)
Global Non-24-hour Sleep-wake Disorder Treatment revenue by player and market share 2018-2023, (USD Million)
Global Non-24-hour Sleep-wake Disorder Treatment total market by Type, CAGR, 2018-2029, (USD Million)
Global Non-24-hour Sleep-wake Disorder Treatment total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Non-24-hour Sleep-wake Disorder Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Mylan, Nature’s Bounty, Otsuka Pharma (Pharmavite), Boiron, Miers Laboratories, Genexa, Homeocan and Clinigen Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Non-24-hour Sleep-wake Disorder Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Non-24-hour Sleep-wake Disorder Treatment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Prescription Drugs
- OTC
- Hospital Pharmacies
- Retail Pharmacies
- Other
- Teva
- Mylan
- Nature’s Bounty
- Otsuka Pharma (Pharmavite)
- Boiron
- Miers Laboratories
- Genexa
- Homeocan
- Clinigen Group
- Vanda Pharma
1. How big is the global Non-24-hour Sleep-wake Disorder Treatment market?
2. What is the demand of the global Non-24-hour Sleep-wake Disorder Treatment market?
3. What is the year over year growth of the global Non-24-hour Sleep-wake Disorder Treatment market?
4. What is the total value of the global Non-24-hour Sleep-wake Disorder Treatment market?
5. Who are the major players in the global Non-24-hour Sleep-wake Disorder Treatment market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Non-24-hour Sleep-wake Disorder Treatment Introduction
1.2 World Non-24-hour Sleep-wake Disorder Treatment Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Non-24-hour Sleep-wake Disorder Treatment Total Market by Region (by Headquarter Location)
1.3.1 World Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)
1.3.3 China Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)
1.3.4 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)
1.3.5 Japan Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)
1.3.6 South Korea Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)
1.3.7 ASEAN Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)
1.3.8 India Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Non-24-hour Sleep-wake Disorder Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Non-24-hour Sleep-wake Disorder Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029)
2.2 World Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Region
2.2.1 World Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Region (2018-2023)
2.2.2 World Non-24-hour Sleep-wake Disorder Treatment Consumption Value Forecast by Region (2024-2029)
2.3 United States Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029)
2.4 China Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029)
2.5 Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029)
2.6 Japan Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029)
2.7 South Korea Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029)
2.8 ASEAN Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029)
2.9 India Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029)
3 WORLD NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT COMPANIES COMPETITIVE ANALYSIS
3.1 World Non-24-hour Sleep-wake Disorder Treatment Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Non-24-hour Sleep-wake Disorder Treatment Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Non-24-hour Sleep-wake Disorder Treatment in 2022
3.2.3 Global Concentration Ratios (CR8) for Non-24-hour Sleep-wake Disorder Treatment in 2022
3.3 Non-24-hour Sleep-wake Disorder Treatment Company Evaluation Quadrant
3.4 Non-24-hour Sleep-wake Disorder Treatment Market: Overall Company Footprint Analysis
3.4.1 Non-24-hour Sleep-wake Disorder Treatment Market: Region Footprint
3.4.2 Non-24-hour Sleep-wake Disorder Treatment Market: Company Product Type Footprint
3.4.3 Non-24-hour Sleep-wake Disorder Treatment Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Non-24-hour Sleep-wake Disorder Treatment Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Non-24-hour Sleep-wake Disorder Treatment Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Non-24-hour Sleep-wake Disorder Treatment Consumption Value Comparison
4.2.1 United States VS China: Non-24-hour Sleep-wake Disorder Treatment Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Non-24-hour Sleep-wake Disorder Treatment Companies and Market Share, 2018-2023
4.3.1 United States Based Non-24-hour Sleep-wake Disorder Treatment Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Non-24-hour Sleep-wake Disorder Treatment Revenue, (2018-2023)
4.4 China Based Companies Non-24-hour Sleep-wake Disorder Treatment Revenue and Market Share, 2018-2023
4.4.1 China Based Non-24-hour Sleep-wake Disorder Treatment Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Non-24-hour Sleep-wake Disorder Treatment Revenue, (2018-2023)
4.5 Rest of World Based Non-24-hour Sleep-wake Disorder Treatment Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Non-24-hour Sleep-wake Disorder Treatment Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Non-24-hour Sleep-wake Disorder Treatment Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Non-24-hour Sleep-wake Disorder Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Prescription Drugs
5.2.2 OTC
5.3 Market Segment by Type
5.3.1 World Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2018-2023)
5.3.2 World Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2024-2029)
5.3.3 World Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Non-24-hour Sleep-wake Disorder Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2018-2023)
6.3.2 World Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2024-2029)
6.3.3 World Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Teva
7.1.1 Teva Details
7.1.2 Teva Major Business
7.1.3 Teva Non-24-hour Sleep-wake Disorder Treatment Product and Services
7.1.4 Teva Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Teva Recent Developments/Updates
7.1.6 Teva Competitive Strengths & Weaknesses
7.2 Mylan
7.2.1 Mylan Details
7.2.2 Mylan Major Business
7.2.3 Mylan Non-24-hour Sleep-wake Disorder Treatment Product and Services
7.2.4 Mylan Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Mylan Recent Developments/Updates
7.2.6 Mylan Competitive Strengths & Weaknesses
7.3 Nature’s Bounty
7.3.1 Nature’s Bounty Details
7.3.2 Nature’s Bounty Major Business
7.3.3 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product and Services
7.3.4 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Nature’s Bounty Recent Developments/Updates
7.3.6 Nature’s Bounty Competitive Strengths & Weaknesses
7.4 Otsuka Pharma (Pharmavite)
7.4.1 Otsuka Pharma (Pharmavite) Details
7.4.2 Otsuka Pharma (Pharmavite) Major Business
7.4.3 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product and Services
7.4.4 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Otsuka Pharma (Pharmavite) Recent Developments/Updates
7.4.6 Otsuka Pharma (Pharmavite) Competitive Strengths & Weaknesses
7.5 Boiron
7.5.1 Boiron Details
7.5.2 Boiron Major Business
7.5.3 Boiron Non-24-hour Sleep-wake Disorder Treatment Product and Services
7.5.4 Boiron Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Boiron Recent Developments/Updates
7.5.6 Boiron Competitive Strengths & Weaknesses
7.6 Miers Laboratories
7.6.1 Miers Laboratories Details
7.6.2 Miers Laboratories Major Business
7.6.3 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product and Services
7.6.4 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Miers Laboratories Recent Developments/Updates
7.6.6 Miers Laboratories Competitive Strengths & Weaknesses
7.7 Genexa
7.7.1 Genexa Details
7.7.2 Genexa Major Business
7.7.3 Genexa Non-24-hour Sleep-wake Disorder Treatment Product and Services
7.7.4 Genexa Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Genexa Recent Developments/Updates
7.7.6 Genexa Competitive Strengths & Weaknesses
7.8 Homeocan
7.8.1 Homeocan Details
7.8.2 Homeocan Major Business
7.8.3 Homeocan Non-24-hour Sleep-wake Disorder Treatment Product and Services
7.8.4 Homeocan Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Homeocan Recent Developments/Updates
7.8.6 Homeocan Competitive Strengths & Weaknesses
7.9 Clinigen Group
7.9.1 Clinigen Group Details
7.9.2 Clinigen Group Major Business
7.9.3 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product and Services
7.9.4 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Clinigen Group Recent Developments/Updates
7.9.6 Clinigen Group Competitive Strengths & Weaknesses
7.10 Vanda Pharma
7.10.1 Vanda Pharma Details
7.10.2 Vanda Pharma Major Business
7.10.3 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product and Services
7.10.4 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Vanda Pharma Recent Developments/Updates
7.10.6 Vanda Pharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Non-24-hour Sleep-wake Disorder Treatment Industry Chain
8.2 Non-24-hour Sleep-wake Disorder Treatment Upstream Analysis
8.3 Non-24-hour Sleep-wake Disorder Treatment Midstream Analysis
8.4 Non-24-hour Sleep-wake Disorder Treatment Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Non-24-hour Sleep-wake Disorder Treatment Introduction
1.2 World Non-24-hour Sleep-wake Disorder Treatment Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Non-24-hour Sleep-wake Disorder Treatment Total Market by Region (by Headquarter Location)
1.3.1 World Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)
1.3.3 China Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)
1.3.4 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)
1.3.5 Japan Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)
1.3.6 South Korea Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)
1.3.7 ASEAN Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)
1.3.8 India Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Non-24-hour Sleep-wake Disorder Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Non-24-hour Sleep-wake Disorder Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029)
2.2 World Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Region
2.2.1 World Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Region (2018-2023)
2.2.2 World Non-24-hour Sleep-wake Disorder Treatment Consumption Value Forecast by Region (2024-2029)
2.3 United States Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029)
2.4 China Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029)
2.5 Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029)
2.6 Japan Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029)
2.7 South Korea Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029)
2.8 ASEAN Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029)
2.9 India Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029)
3 WORLD NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT COMPANIES COMPETITIVE ANALYSIS
3.1 World Non-24-hour Sleep-wake Disorder Treatment Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Non-24-hour Sleep-wake Disorder Treatment Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Non-24-hour Sleep-wake Disorder Treatment in 2022
3.2.3 Global Concentration Ratios (CR8) for Non-24-hour Sleep-wake Disorder Treatment in 2022
3.3 Non-24-hour Sleep-wake Disorder Treatment Company Evaluation Quadrant
3.4 Non-24-hour Sleep-wake Disorder Treatment Market: Overall Company Footprint Analysis
3.4.1 Non-24-hour Sleep-wake Disorder Treatment Market: Region Footprint
3.4.2 Non-24-hour Sleep-wake Disorder Treatment Market: Company Product Type Footprint
3.4.3 Non-24-hour Sleep-wake Disorder Treatment Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Non-24-hour Sleep-wake Disorder Treatment Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Non-24-hour Sleep-wake Disorder Treatment Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Non-24-hour Sleep-wake Disorder Treatment Consumption Value Comparison
4.2.1 United States VS China: Non-24-hour Sleep-wake Disorder Treatment Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Non-24-hour Sleep-wake Disorder Treatment Companies and Market Share, 2018-2023
4.3.1 United States Based Non-24-hour Sleep-wake Disorder Treatment Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Non-24-hour Sleep-wake Disorder Treatment Revenue, (2018-2023)
4.4 China Based Companies Non-24-hour Sleep-wake Disorder Treatment Revenue and Market Share, 2018-2023
4.4.1 China Based Non-24-hour Sleep-wake Disorder Treatment Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Non-24-hour Sleep-wake Disorder Treatment Revenue, (2018-2023)
4.5 Rest of World Based Non-24-hour Sleep-wake Disorder Treatment Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Non-24-hour Sleep-wake Disorder Treatment Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Non-24-hour Sleep-wake Disorder Treatment Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Non-24-hour Sleep-wake Disorder Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Prescription Drugs
5.2.2 OTC
5.3 Market Segment by Type
5.3.1 World Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2018-2023)
5.3.2 World Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2024-2029)
5.3.3 World Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Non-24-hour Sleep-wake Disorder Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2018-2023)
6.3.2 World Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2024-2029)
6.3.3 World Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Teva
7.1.1 Teva Details
7.1.2 Teva Major Business
7.1.3 Teva Non-24-hour Sleep-wake Disorder Treatment Product and Services
7.1.4 Teva Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Teva Recent Developments/Updates
7.1.6 Teva Competitive Strengths & Weaknesses
7.2 Mylan
7.2.1 Mylan Details
7.2.2 Mylan Major Business
7.2.3 Mylan Non-24-hour Sleep-wake Disorder Treatment Product and Services
7.2.4 Mylan Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Mylan Recent Developments/Updates
7.2.6 Mylan Competitive Strengths & Weaknesses
7.3 Nature’s Bounty
7.3.1 Nature’s Bounty Details
7.3.2 Nature’s Bounty Major Business
7.3.3 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product and Services
7.3.4 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Nature’s Bounty Recent Developments/Updates
7.3.6 Nature’s Bounty Competitive Strengths & Weaknesses
7.4 Otsuka Pharma (Pharmavite)
7.4.1 Otsuka Pharma (Pharmavite) Details
7.4.2 Otsuka Pharma (Pharmavite) Major Business
7.4.3 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product and Services
7.4.4 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Otsuka Pharma (Pharmavite) Recent Developments/Updates
7.4.6 Otsuka Pharma (Pharmavite) Competitive Strengths & Weaknesses
7.5 Boiron
7.5.1 Boiron Details
7.5.2 Boiron Major Business
7.5.3 Boiron Non-24-hour Sleep-wake Disorder Treatment Product and Services
7.5.4 Boiron Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Boiron Recent Developments/Updates
7.5.6 Boiron Competitive Strengths & Weaknesses
7.6 Miers Laboratories
7.6.1 Miers Laboratories Details
7.6.2 Miers Laboratories Major Business
7.6.3 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product and Services
7.6.4 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Miers Laboratories Recent Developments/Updates
7.6.6 Miers Laboratories Competitive Strengths & Weaknesses
7.7 Genexa
7.7.1 Genexa Details
7.7.2 Genexa Major Business
7.7.3 Genexa Non-24-hour Sleep-wake Disorder Treatment Product and Services
7.7.4 Genexa Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Genexa Recent Developments/Updates
7.7.6 Genexa Competitive Strengths & Weaknesses
7.8 Homeocan
7.8.1 Homeocan Details
7.8.2 Homeocan Major Business
7.8.3 Homeocan Non-24-hour Sleep-wake Disorder Treatment Product and Services
7.8.4 Homeocan Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Homeocan Recent Developments/Updates
7.8.6 Homeocan Competitive Strengths & Weaknesses
7.9 Clinigen Group
7.9.1 Clinigen Group Details
7.9.2 Clinigen Group Major Business
7.9.3 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product and Services
7.9.4 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Clinigen Group Recent Developments/Updates
7.9.6 Clinigen Group Competitive Strengths & Weaknesses
7.10 Vanda Pharma
7.10.1 Vanda Pharma Details
7.10.2 Vanda Pharma Major Business
7.10.3 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product and Services
7.10.4 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Vanda Pharma Recent Developments/Updates
7.10.6 Vanda Pharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Non-24-hour Sleep-wake Disorder Treatment Industry Chain
8.2 Non-24-hour Sleep-wake Disorder Treatment Upstream Analysis
8.3 Non-24-hour Sleep-wake Disorder Treatment Midstream Analysis
8.4 Non-24-hour Sleep-wake Disorder Treatment Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Non-24-hour Sleep-wake Disorder Treatment Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Non-24-hour Sleep-wake Disorder Treatment Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Non-24-hour Sleep-wake Disorder Treatment Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Non-24-hour Sleep-wake Disorder Treatment Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Non-24-hour Sleep-wake Disorder Treatment Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Non-24-hour Sleep-wake Disorder Treatment Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Non-24-hour Sleep-wake Disorder Treatment Players in 2022
Table 12. World Non-24-hour Sleep-wake Disorder Treatment Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Non-24-hour Sleep-wake Disorder Treatment Company Evaluation Quadrant
Table 14. Head Office of Key Non-24-hour Sleep-wake Disorder Treatment Player
Table 15. Non-24-hour Sleep-wake Disorder Treatment Market: Company Product Type Footprint
Table 16. Non-24-hour Sleep-wake Disorder Treatment Market: Company Product Application Footprint
Table 17. Non-24-hour Sleep-wake Disorder Treatment Mergers & Acquisitions Activity
Table 18. United States VS China Non-24-hour Sleep-wake Disorder Treatment Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Non-24-hour Sleep-wake Disorder Treatment Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Non-24-hour Sleep-wake Disorder Treatment Companies, Headquarters (States, Country)
Table 21. United States Based Companies Non-24-hour Sleep-wake Disorder Treatment Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share (2018-2023)
Table 23. China Based Non-24-hour Sleep-wake Disorder Treatment Companies, Headquarters (Province, Country)
Table 24. China Based Companies Non-24-hour Sleep-wake Disorder Treatment Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share (2018-2023)
Table 26. Rest of World Based Non-24-hour Sleep-wake Disorder Treatment Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Non-24-hour Sleep-wake Disorder Treatment Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share (2018-2023)
Table 29. World Non-24-hour Sleep-wake Disorder Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2018-2023) & (USD Million)
Table 31. World Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2024-2029) & (USD Million)
Table 32. World Non-24-hour Sleep-wake Disorder Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2018-2023) & (USD Million)
Table 34. World Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2024-2029) & (USD Million)
Table 35. Teva Basic Information, Area Served and Competitors
Table 36. Teva Major Business
Table 37. Teva Non-24-hour Sleep-wake Disorder Treatment Product and Services
Table 38. Teva Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Teva Recent Developments/Updates
Table 40. Teva Competitive Strengths & Weaknesses
Table 41. Mylan Basic Information, Area Served and Competitors
Table 42. Mylan Major Business
Table 43. Mylan Non-24-hour Sleep-wake Disorder Treatment Product and Services
Table 44. Mylan Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Mylan Recent Developments/Updates
Table 46. Mylan Competitive Strengths & Weaknesses
Table 47. Nature’s Bounty Basic Information, Area Served and Competitors
Table 48. Nature’s Bounty Major Business
Table 49. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product and Services
Table 50. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Nature’s Bounty Recent Developments/Updates
Table 52. Nature’s Bounty Competitive Strengths & Weaknesses
Table 53. Otsuka Pharma (Pharmavite) Basic Information, Area Served and Competitors
Table 54. Otsuka Pharma (Pharmavite) Major Business
Table 55. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product and Services
Table 56. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Otsuka Pharma (Pharmavite) Recent Developments/Updates
Table 58. Otsuka Pharma (Pharmavite) Competitive Strengths & Weaknesses
Table 59. Boiron Basic Information, Area Served and Competitors
Table 60. Boiron Major Business
Table 61. Boiron Non-24-hour Sleep-wake Disorder Treatment Product and Services
Table 62. Boiron Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Boiron Recent Developments/Updates
Table 64. Boiron Competitive Strengths & Weaknesses
Table 65. Miers Laboratories Basic Information, Area Served and Competitors
Table 66. Miers Laboratories Major Business
Table 67. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product and Services
Table 68. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Miers Laboratories Recent Developments/Updates
Table 70. Miers Laboratories Competitive Strengths & Weaknesses
Table 71. Genexa Basic Information, Area Served and Competitors
Table 72. Genexa Major Business
Table 73. Genexa Non-24-hour Sleep-wake Disorder Treatment Product and Services
Table 74. Genexa Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Genexa Recent Developments/Updates
Table 76. Genexa Competitive Strengths & Weaknesses
Table 77. Homeocan Basic Information, Area Served and Competitors
Table 78. Homeocan Major Business
Table 79. Homeocan Non-24-hour Sleep-wake Disorder Treatment Product and Services
Table 80. Homeocan Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Homeocan Recent Developments/Updates
Table 82. Homeocan Competitive Strengths & Weaknesses
Table 83. Clinigen Group Basic Information, Area Served and Competitors
Table 84. Clinigen Group Major Business
Table 85. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product and Services
Table 86. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Clinigen Group Recent Developments/Updates
Table 88. Vanda Pharma Basic Information, Area Served and Competitors
Table 89. Vanda Pharma Major Business
Table 90. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product and Services
Table 91. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Non-24-hour Sleep-wake Disorder Treatment Upstream (Raw Materials)
Table 93. Non-24-hour Sleep-wake Disorder Treatment Typical Customers
Table 1. World Non-24-hour Sleep-wake Disorder Treatment Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Non-24-hour Sleep-wake Disorder Treatment Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Non-24-hour Sleep-wake Disorder Treatment Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Non-24-hour Sleep-wake Disorder Treatment Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Non-24-hour Sleep-wake Disorder Treatment Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Non-24-hour Sleep-wake Disorder Treatment Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Non-24-hour Sleep-wake Disorder Treatment Players in 2022
Table 12. World Non-24-hour Sleep-wake Disorder Treatment Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Non-24-hour Sleep-wake Disorder Treatment Company Evaluation Quadrant
Table 14. Head Office of Key Non-24-hour Sleep-wake Disorder Treatment Player
Table 15. Non-24-hour Sleep-wake Disorder Treatment Market: Company Product Type Footprint
Table 16. Non-24-hour Sleep-wake Disorder Treatment Market: Company Product Application Footprint
Table 17. Non-24-hour Sleep-wake Disorder Treatment Mergers & Acquisitions Activity
Table 18. United States VS China Non-24-hour Sleep-wake Disorder Treatment Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Non-24-hour Sleep-wake Disorder Treatment Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Non-24-hour Sleep-wake Disorder Treatment Companies, Headquarters (States, Country)
Table 21. United States Based Companies Non-24-hour Sleep-wake Disorder Treatment Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share (2018-2023)
Table 23. China Based Non-24-hour Sleep-wake Disorder Treatment Companies, Headquarters (Province, Country)
Table 24. China Based Companies Non-24-hour Sleep-wake Disorder Treatment Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share (2018-2023)
Table 26. Rest of World Based Non-24-hour Sleep-wake Disorder Treatment Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Non-24-hour Sleep-wake Disorder Treatment Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share (2018-2023)
Table 29. World Non-24-hour Sleep-wake Disorder Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2018-2023) & (USD Million)
Table 31. World Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2024-2029) & (USD Million)
Table 32. World Non-24-hour Sleep-wake Disorder Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2018-2023) & (USD Million)
Table 34. World Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2024-2029) & (USD Million)
Table 35. Teva Basic Information, Area Served and Competitors
Table 36. Teva Major Business
Table 37. Teva Non-24-hour Sleep-wake Disorder Treatment Product and Services
Table 38. Teva Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Teva Recent Developments/Updates
Table 40. Teva Competitive Strengths & Weaknesses
Table 41. Mylan Basic Information, Area Served and Competitors
Table 42. Mylan Major Business
Table 43. Mylan Non-24-hour Sleep-wake Disorder Treatment Product and Services
Table 44. Mylan Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Mylan Recent Developments/Updates
Table 46. Mylan Competitive Strengths & Weaknesses
Table 47. Nature’s Bounty Basic Information, Area Served and Competitors
Table 48. Nature’s Bounty Major Business
Table 49. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product and Services
Table 50. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Nature’s Bounty Recent Developments/Updates
Table 52. Nature’s Bounty Competitive Strengths & Weaknesses
Table 53. Otsuka Pharma (Pharmavite) Basic Information, Area Served and Competitors
Table 54. Otsuka Pharma (Pharmavite) Major Business
Table 55. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product and Services
Table 56. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Otsuka Pharma (Pharmavite) Recent Developments/Updates
Table 58. Otsuka Pharma (Pharmavite) Competitive Strengths & Weaknesses
Table 59. Boiron Basic Information, Area Served and Competitors
Table 60. Boiron Major Business
Table 61. Boiron Non-24-hour Sleep-wake Disorder Treatment Product and Services
Table 62. Boiron Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Boiron Recent Developments/Updates
Table 64. Boiron Competitive Strengths & Weaknesses
Table 65. Miers Laboratories Basic Information, Area Served and Competitors
Table 66. Miers Laboratories Major Business
Table 67. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product and Services
Table 68. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Miers Laboratories Recent Developments/Updates
Table 70. Miers Laboratories Competitive Strengths & Weaknesses
Table 71. Genexa Basic Information, Area Served and Competitors
Table 72. Genexa Major Business
Table 73. Genexa Non-24-hour Sleep-wake Disorder Treatment Product and Services
Table 74. Genexa Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Genexa Recent Developments/Updates
Table 76. Genexa Competitive Strengths & Weaknesses
Table 77. Homeocan Basic Information, Area Served and Competitors
Table 78. Homeocan Major Business
Table 79. Homeocan Non-24-hour Sleep-wake Disorder Treatment Product and Services
Table 80. Homeocan Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Homeocan Recent Developments/Updates
Table 82. Homeocan Competitive Strengths & Weaknesses
Table 83. Clinigen Group Basic Information, Area Served and Competitors
Table 84. Clinigen Group Major Business
Table 85. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product and Services
Table 86. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Clinigen Group Recent Developments/Updates
Table 88. Vanda Pharma Basic Information, Area Served and Competitors
Table 89. Vanda Pharma Major Business
Table 90. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product and Services
Table 91. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Non-24-hour Sleep-wake Disorder Treatment Upstream (Raw Materials)
Table 93. Non-24-hour Sleep-wake Disorder Treatment Typical Customers
LIST OF FIGURES
Figure 1. Non-24-hour Sleep-wake Disorder Treatment Picture
Figure 2. World Non-24-hour Sleep-wake Disorder Treatment Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Non-24-hour Sleep-wake Disorder Treatment Total Market Size (2018-2029) & (USD Million)
Figure 4. World Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Non-24-hour Sleep-wake Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Non-24-hour Sleep-wake Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Non-24-hour Sleep-wake Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Non-24-hour Sleep-wake Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Non-24-hour Sleep-wake Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Non-24-hour Sleep-wake Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Non-24-hour Sleep-wake Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 13. Non-24-hour Sleep-wake Disorder Treatment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 16. World Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 18. China Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. India Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Non-24-hour Sleep-wake Disorder Treatment by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Non-24-hour Sleep-wake Disorder Treatment Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Non-24-hour Sleep-wake Disorder Treatment Markets in 2022
Figure 27. United States VS China: Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Non-24-hour Sleep-wake Disorder Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type in 2022
Figure 31. Prescription Drugs
Figure 32. OTC
Figure 33. World Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type (2018-2029)
Figure 34. World Non-24-hour Sleep-wake Disorder Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Application in 2022
Figure 36. Hospital Pharmacies
Figure 37. Retail Pharmacies
Figure 38. Other
Figure 39. Non-24-hour Sleep-wake Disorder Treatment Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. Non-24-hour Sleep-wake Disorder Treatment Picture
Figure 2. World Non-24-hour Sleep-wake Disorder Treatment Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Non-24-hour Sleep-wake Disorder Treatment Total Market Size (2018-2029) & (USD Million)
Figure 4. World Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Non-24-hour Sleep-wake Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Non-24-hour Sleep-wake Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Non-24-hour Sleep-wake Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Non-24-hour Sleep-wake Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Non-24-hour Sleep-wake Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Non-24-hour Sleep-wake Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Non-24-hour Sleep-wake Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 13. Non-24-hour Sleep-wake Disorder Treatment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 16. World Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 18. China Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. India Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Non-24-hour Sleep-wake Disorder Treatment by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Non-24-hour Sleep-wake Disorder Treatment Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Non-24-hour Sleep-wake Disorder Treatment Markets in 2022
Figure 27. United States VS China: Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Non-24-hour Sleep-wake Disorder Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type in 2022
Figure 31. Prescription Drugs
Figure 32. OTC
Figure 33. World Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type (2018-2029)
Figure 34. World Non-24-hour Sleep-wake Disorder Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Application in 2022
Figure 36. Hospital Pharmacies
Figure 37. Retail Pharmacies
Figure 38. Other
Figure 39. Non-24-hour Sleep-wake Disorder Treatment Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
